Vaccine Market Will Lead Pharmaceutical Industry In China And Globally, Frost & Sullivan Predicts
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The compound annual growth rate of the global pharmaceutical industry is expected to be around 4-5 percent in the next seven years, while the worldwide vaccine market grows faster, at a CAGR of 14-15 percent, the global business research and consulting firm Frost & Sullivan predicted
You may also be interested in...
China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
SHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices
China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
SHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices
China's Changing Drug Market In The Wake Of Essential Drugs List
SHANGHAI - As an important part of China's $850 billion healthcare reform plan, the Essential Drug List system will bring new challenges as well as opportunities for all players in China's drug supply chain